Menu

Facing Brexit, U.K. Makes Science Deal with U.S.

The $88 million agreement is part of efforts by the UK government to increase transatlantic collaboration as the country prepares to leave the European Union.

Sep 22, 2017
Catherine Offord

ISTOCK, LEPETTETThe U.K. has committed $88 million to a new collaboration dubbed the UK-US Science and Technology Agreement, the UK government announced on Wednesday (September 20). Signed by UK science minister Jo Johnson and US State Department official Judith Garber, the agreement outlines the countries’ commitments to cooperation on scientific research, and is part of a larger effort by the UK government to strengthen transatlantic ties amidst fears that British science will take a hit after Brexit.

The deal “involves us in one of the most exciting new physics experiments in the world,” Johnson tells ScienceInsider. “We’re delighted to be a part of it.”

The Deep Underground Neutrino Experiment (DUNE) aims to use particle accelerators to advance scientists’ understanding of the structure and origin of the universe. The U.K. is already involved in the project, and has 150 of its scientists working as part of a 1,000-researcher strong program based in the U.S. But the current investment will make the U.K. the largest financial contributor after the States, Times Higher Education reports.

“This agreement sends a welcome message that UK science remains outward looking,” Venki Ramakrishnan, president of the Royal Society, tells the BBC. “International research collaboration allows the rapid exchange of new ideas and expertise and it also allows us to address problems that no one country can on its own.” Ramakrishnan also expressed concern that plans for future scientific collaboration with the E.U. after Brexit—part of what ministers have described as a “special relationship”—still lack detail.

See “U.K. Lays Out Its Vision for Post-Brexit Research

Meanwhile, signs that UK-EU collaboration is suffering following the referendum for Britain to leave the E.U. gained some support from a report published yesterday (September 21) by Nature. Data reveal a dip in applications from European researchers seeking funding to work in the U.K. after 2016, although the report also noted that the U.K. is still performing well in grant applications submitted to the European Research Council.

For now, the timescale may be too short to draw meaningful conclusions, because change is likely to be slow, notes the University of Manchester’s Andre Geim, a Nobel prize-winning physicist who has been vocal about the negative effects of Brexit on research. “It’s unreasonable to expect an immediate effect from Brexit,” he tells Nature. “The university and research system in the UK is massive, and it will take many years for the system to bleed out and gradually lose its competitiveness.”

See “Scientists’ Expectations for Brexit Mostly Grim

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.